Concurrent Session 4D: Artificial Intelligence in Medicine; CME (AMA PRA Category 1 CreditsTM) 1.5; ACPE 1.5; Attendance CEU 1.5

Thursday, September 13
1:45 PM - 3:15 PM
Location: Mayo Civic Center Rooms 112-113

Artificial Intelligence is already influencing a physician’s diagnostic decision making by generating “actionable intelligence” in patient-specific therapeutic choices.  This session will highlight recent successes and challenges in developing algorithmic and systems innovations for translation to the bedside.  

Learning Objectives:

Moderator :
Eric W. Klee, PhD

CONS-RESEARCH
Mayo Clinic

Eric W. Klee, PhD is a Consultant in the Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, with joint appointments in the Department of Medical Genetics and in the Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology. He serves as director of the Bioinformatics Core, Department of Laboratory Medicine and Pathology, and associate director of Bioinformatics, Mayo Clinic Center for Individualized Medicine. Dr. Klee holds the academic rank of associate professor of medical informatics, Mayo Clinic College of Medicine and Science. He joined the staff of Mayo Clinic in 2005.


Dr. Klee’s research within the Center for Individualized Medicine is focused on the application of genomics to improve patient care. He directs the Translational Research Program that uses multi-omic, protein modeling, and functional studies to understand and aid in the diagnosis and treatment of rare or previously undiagnosed diseases. Additionally, Dr. Klee works with the Department of Laboratory Medicine and Pathology to develop new methods for improving diagnostic NGS testing. He consistently publishes in high-impact scientific journals and is frequently invited to give presentations on his research. He has authored numerous journal articles, abstracts and other written publications.

In recognition of his work, Dr. Klee received the National Academy of Clinical Biochemistry Distinguished Abstract Award, conferred by the National Academy for Clinical Biochemistry, and he was selected for the KL2 Mentored Career Development Program through the Mayo Clinic Center for Translational Science Activities.

Presentation(s):

Send Email for Eric Klee

Concurrent Speaker :
Konstantinos Lazaridis, MD

Professor of Medicine, College of Medicine and Science
Center for Individualized Medicine
Mayo Clinic
Rochester, Minnesota

Konstantinos Lazaridis, MD is considered a leader in the area of the genomics of chronic cholestatic liver diseases, namely, Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC). Since 2003, he has established and is the principal investigator of the two national consortia for studying patients afflicted with these diseases. His research group applies the latest genomic and genetic epidemiology approaches to better understand the pathogenesis and improve the therapy of patients with PBC and PSC. This research effort is supported by the NIH. He was elected to the American Society of Clinical Investigation (ASCI) in 2015.

As associate director of the Center for Individualized Medicine in Rochester, Dr. Lazaridis has been instrumental in establishing and expanding the Individualized Medicine Clinic and in directing the Clinomics program that seeks to integrate the latest genomic discoveries into clinical care. Dr. Lazaridis is a physician in the Division of Gastroenterology and Hepatology and the Everett J. and Jane M. Hauck Associate Director, Center for Individualized Medicine, Mayo Clinic in Rochester. Dr. Lazaridis received his medical degree at the University of Ioannina in Greece. He completed his Internal Medicine and Gastroenterology fellowship training at Mayo Clinic and was a Mayo Clinic Scholar in Genomics in the laboratory of Dr. Francis Collins at the National Human Genome Research Institute.

Presentation(s):

Send Email for Konstantinos Lazaridis

Concurrent Speaker :
Arjun P. Athreya, MS

Fellow
Electrical and Computer Engineering
University of Illinois at Urbana-Champaign
Urbana, Illinois

Arjun Prasanna Athreya is a predoctoral Fellow in the department of Electrical and Computer Engineering (ECE) at the Univ. Illinois at Urbana-Champaign. Arjun is advised by Prof. Ravishankar K. Iyer in the DEPEND laboratory at the Coordinated Science Laboratory, and closely mentored by Drs. Richard Weinshilboum, Liewei Wang and William V. Bobo at Mayo Clinic. Arjun is also the inaugural Fellow of Mayo Clinic and Illinois Alliance for advancing Technology-based Healthcare Research. His research interests are in developing and applying machine learning/artificial intelligence methods on clinical and biological big data to bring predictability in clinical therapeutics to enable precision medicine. Arjun is currently developing analytical framework for precision medicine approaches in psychiatry, breast oncology and liver cancer. At the core of Arjun's work is the use of probabilistic graphical models in combination with other machine learning approaches that offer high-degrees of interpretability from a clinician's perspective and the developed framework is currently being engineered for deployment in several hospitals around the world. Arjun's collaboration extends to Max Planck Institute of Psychiatry, Germany, National University Hospital, Singapore and Emory University, USA. Prior to joining Univ. of Illinois, Arjun received his MS in ECE from Carnegie Mellon University, with interests in networks and system security.

Presentation(s):

Send Email for Arjun Athreya

Concurrent Speaker :
William V. Bobo, MD

Professor of Psychiatry, College of Medicine and Science
Psychiatry and Psychology
Mayo Clinic
Rochester, Minnesota

William V. Bobo, MD, MPH is Associate Professor of Psychiatry in the Mayo Clinic College of Medicine, Co-Chair for the Division of Outpatient Consultation in the Department of Psychiatry & Psychology at Mayo Clinic, and medical director of the Mayo Clinic Mood Disorders Program. He has published extensively on psychiatric epidemiology and pharmacoepidemiology, and clinical trials of pharmacotherapy for patients with severe mood disorders. He splits his time between patient care at the Mayo Clinic Depression Center, research, teaching of residents, and administrative duties.

Presentation(s):

Send Email for William Bobo

Concurrent Speaker :
Boadie W. Dunlop, MD

Associate Professor
Psychiatry and Behavioral Sciences
Emory University School of Medicine

Boadie Dunlop, MD, MS is an Associate Professor of Psychiatry and Behavioral Sciences and Director of the Mood and Anxiety Disorders Program at Emory University. His primary research interest is in the application of biomarkers for use in personalized medicine for depression, posttraumatic stress disorder, and anxiety disorders, particularly in the realms of neuroimaging and metabolomics. His other research interests include testing investigational medications for these disorders, and in the design and conduct of clinical trials. Dr. Dunlop also serves as the Medical Director the Emory Healthcare Veterans Program and supervises a psychopharmacology specialty clinic as part of the psychiatry residency training program at the Emory University School of Medicine.

Presentation(s):

Send Email for Boadie Dunlop

Concurrent Speaker :
Ravishankar K. Iyer, PhD

Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America

Presentation(s):

Send Email for Ravishankar Iyer

Concurrent Speaker :
Konstantinos Lazaridis, MD

Professor of Medicine, College of Medicine and Science
Center for Individualized Medicine
Mayo Clinic
Rochester, Minnesota

Konstantinos Lazaridis, MD is considered a leader in the area of the genomics of chronic cholestatic liver diseases, namely, Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC). Since 2003, he has established and is the principal investigator of the two national consortia for studying patients afflicted with these diseases. His research group applies the latest genomic and genetic epidemiology approaches to better understand the pathogenesis and improve the therapy of patients with PBC and PSC. This research effort is supported by the NIH. He was elected to the American Society of Clinical Investigation (ASCI) in 2015.

As associate director of the Center for Individualized Medicine in Rochester, Dr. Lazaridis has been instrumental in establishing and expanding the Individualized Medicine Clinic and in directing the Clinomics program that seeks to integrate the latest genomic discoveries into clinical care. Dr. Lazaridis is a physician in the Division of Gastroenterology and Hepatology and the Everett J. and Jane M. Hauck Associate Director, Center for Individualized Medicine, Mayo Clinic in Rochester. Dr. Lazaridis received his medical degree at the University of Ioannina in Greece. He completed his Internal Medicine and Gastroenterology fellowship training at Mayo Clinic and was a Mayo Clinic Scholar in Genomics in the laboratory of Dr. Francis Collins at the National Human Genome Research Institute.

Presentation(s):

Send Email for Konstantinos Lazaridis


Assets

Concurrent Session 4D: Artificial Intelligence in Medicine; CME (AMA PRA Category 1 CreditsTM) 1.5; ACPE 1.5; Attendance CEU 1.5

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Concurrent Session 4D: Artificial Intelligence in Medicine; CME (AMA PRA Category 1 CreditsTM) 1.5; ACPE 1.5; Attendance CEU 1.5